Best of February: Top 5 Insights In Clinical Research

#1 Ramblings From A First-Time SCOPE Attendee

Dan Schell, chief editor of Clinical Leader, discusses what sessions stood out to him and some of the KOLs he rubbed elbows with while attending his first SCOPE Summit in Orlando, Florida.

#2 Diversity In Clinical Trials: How Companies Are Tackling The Issue

Experts from Genentech, Moderna, and Patientory share how collaborative approaches involving technology and multiple resources can improve health outcomes and increase diversity in clinical trials.

#3 FDA Draft Guidance On “Rare Diseases: Considerations For The Development Of Drugs And Biological Products”

Accenture Applied Life Science Solutions' Raj Bandaru, Ph.D. breaks down, summarizes, and shares detailed insight on the recent FDA Draft Guidance that addresses “Rare Diseases: Considerations for the Development of Drugs and Biological Products.”

#4 2024: The Year Of EHR eSource In Clinical Trials

The anticipated surge in momentum suggests that 2024 is poised to become the pivotal year for EHR eSource adoption. Discover 10 compelling reasons to elevate your approach and enhance clinical research outcomes.

#5 6 Things Rare Disease Patients Want Sponsors To Know About Clinical Trials

A rare disease caregiver and patient, Sabina Kineen hopes to shine a light both on the importance of clinical trial education for patients and caregivers and on the specific ways sponsors can support them.